Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Pharm (128940 KS)
Watchlist
142
Analysis
Health Care
•
South Korea
Hanmi Pharm. Company Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
27 Feb 2021 03:50
Asia Short Interest: Kuaishou, BYD, Galaxy, Sharp, Resona, Toshiba, Celltrion, Naver, Pegatron, TSMC
The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
478 Views
Share
bearish
•
Pearl Abyss
•
21 Feb 2021 16:19
KRX BBIG K-NewDeal Index Rebalance: First Set of Changes Announced
The KRX has announced changes to the KRX New Deal indices that will be effective after the close of trading on 25 February. Pearl Abyss is...
Brian Freitas
Follow
735 Views
Share
bearish
•
Amorepacific Holdings
•
16 Mar 2020 03:26
Korean Stub Trade in a New Era: List of Holdcos Having Single Stock Futures
We now have the across-the-board shorting restriction in Korea for the next six months. It means that we will have to adjust our approach on most...
Sanghyun Park
Follow
606 Views
Share
bullish
•
SK Telecom
•
09 Oct 2017 03:05
SK Group Restructuring - Local Institutions Are Already Making A Move
We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...
Sanghyun Park
Follow
495 Views
Share
bullish
•
Yuhan Corp
•
27 Dec 2016 15:50
Yuhan Corp: (Part I) - Oversold on Hanmi Pharma Scares
Why Look atYuhan Corp?Yuhan Corp shares are quite interesting at current levels. It is currently trading at 214,000 won, which is down 38% (A...
Douglas Kim
Follow
1.4k Views
Share
First
Previous
23
24
25
26
27
28
29
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x